Advanced breast cancer clinical nursing curriculum: review
and recommendations by Vila, C. et al.
RESEARCH ARTICLE
Advanced breast cancer clinical nursing curriculum: review
and recommendations
C. Vila1 • C. Ren˜ones2 • T. Ferro3 • Ma. A´. Pen˜uelas4 • M. del Mar Jime´nez5 •
A´. Rodrı´guez-Lescure6 • M. Mun˜oz7 • R. Colomer8
Received: 6 June 2016 / Accepted: 9 July 2016 / Published online: 3 August 2016
 The Author(s) 2016. This article is published with open access at Springerlink.com
Abstract
Purpose The needs and concerns of patients with advanced
breast cancer are changing at every phase of the care
intervention. Management and coordination of hospital
resources and services are also steadily evolving. The
objective of the present expert report is to define a new
oncology nursing role specialising in advanced breast
cancer, to help guide patients throughout the whole
healthcare itinerary.
Methods A group of eight experts in oncology nursing and
medical oncology defined the content index of the cur-
riculum document. A systematic review of bibliography
was carried out, and the relevant contents were extracted.
Based on these contents and the participants’ experience,
recommendations were formulated and validated through a
Delphi questionnaire and a participative meeting.
Results The advanced breast cancer clinical nurse
(ABCCN) should develop a clinical, psychosocial role
focused on coordinating patients in the healthcare network.
The nurse would be in charge of evaluating and supervising
the care administered and the healthcare resources used.
The ABCCN should be aware and participate in the pro-
tocols and available resources, be able to solve conflicts,
deal with burn-out signs and have clinical, coaching and
team-working abilities. The proposed curriculum provides
a specific process for the care of patients, as well as an
implementation process.
Conclusions The ABCCN’s role is crucial to assume the
best care and the optimisation of available resources. This
review and consensus document provides the required tools
for the implementation in hospitals.
Keywords Breast neoplasms  Oncology nursing  Case
management  Patient navigation  Counselling  Consensus
Introduction and objectives
Breast cancer is the most common tumour among women
in developed countries [1], and approximately one-third of
patients in the clinic have advanced disease [2, 3].
In recent years, there has been much progress in thera-
peutic options in advanced breast cancer, which has
increased the disease control and has significantly con-
tributed to improving prognosis in a substantial proportion
of patients. These patients require complex intervention
and care, as well as good coordination of all specialists
involved. These factors significantly influence on patients’
prognosis and quality of life [4, 5].
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NICE guidelines on the management of advanced breast
cancer emphasise the need to assess the physical, psycho-
logical, social, spiritual and financial needs of patients at
some key points in the course of the disease: diagnosis,
start of treatment, end of treatment, relapses and end of life
[6]. Guidelines include the designation of a healthcare
provider assuming the role of ‘‘key worker’’ for each
patient and promoting continuous care [6]. Nursing pro-
fessionals, in particular, have a key role in the management
of patients with advanced breast cancer, contributing with
their perspective on patients’ experience in different ther-
apeutic and medical situations. In coordination with
oncologists specialised in breast cancer, they can accelerate
healthcare processes, improve continuous care and min-
imise symptoms and adverse effects of treatment, as well
as help patients cope with fears, improve relationship with
their environment, detect situations of particular fragility
and achieve quicker interventions.
There is no current consensus document or curriculum
in Spain that defines the professional profile, roles or
activities of an advanced breast cancer clinical nurse
(ABCCN). The purpose of this document is to review and
establish a consensus on the activities to be performed by
nursing professionals in an advanced breast cancer
patients’ care consultation, as well as to turn nursing pro-
fessionals into key members on multidisciplinary teams
and providers of comprehensive support to patients, espe-
cially in terms of emotional considerations, health educa-
tion and follow-up of toxicities. The ABCCN can help
achieve better self-care among patients, greater treatment
adherence and a decrease in oncological emergencies.
Methods
This document of recommendations was developed by a
multidisciplinary team composed of eight experts in
oncology nursing and medical oncology, following the
Methodological Manual for the Preparation of Clinical
Practice Guidelines in the Spanish National Health System
(Elaboracio´n de Guı´as de Pra´ctica Clı´nica en el Sistema
Nacional de Salud. Manual metodolo´gico), which forms
part of the Quality Plan of the Spanish Ministry of Health
[7].
At the start of the process, a coordinating committee
(CC), with three experts, and a recommendation-formu-
lating group (RFG), composed of the members of the CC
and five more experts were formed. All of them developed,
in an initial face-to-face meeting in December 2014, a
content index and a list of clinical questions to be
addressed. Subsequently, a systematic literature search was
conducted in three databases (MEDLINE, Trip database
and ENFISPO). A total of 236 publications were obtained.
At the CC’s discretion, a total of 56 publications were
prioritised. After reading them, a document answering each
clinical question and including potential recommendations
was prepared. Next, the recommendations were assessed
individually by each RFG member, without any kind of
communication or exchange of opinions. Both non-con-
sensus recommendations and consensus recommendations
liable to change at the CC’s discretion were debated during
a structured participatory face-to-face meeting in July
2015. Recommendations that achieved unanimity (100 %
agreement) or consensus (C80 % agreement) were accep-
ted as definitive. At the end of the process, a total of 147
recommendations (131 by unanimity and 16 by consensus)
were validated. The most important recommendations were
formally categorised with their level of evidence (LE) and
degree of recommendation (DR), according to the modified
version of the Scottish Intercollegiate Guidelines Network
system [8].
Results
Roles and activities of the ABCCN
Clinical role
Median survival for advanced breast cancer is *3 years.
During the survival period, the entire set of therapeutic
strategies––hormone therapy, chemotherapy, targeted
therapies, radiotherapy and palliative care––is applied in
different sequences or combinations [9].
Given that throughout the course of the disease, there are
constant variations in the type, dose and frequency of
treatment, the clinical management of patients with
advanced breast cancer should cover their needs at all points
in the process, ensuring comprehensive quality care and
being based, at all times, on clinical practice guidelines
(Agreement: 100 %; LE/DR: 4/D) [10, 11]. The ABCCN
should participate in continuous care and in clinical man-
agement, providing information and access to diagnosis
tests, administering oncological and complementary treat-
ments and managing adverse effects and pain (Agreement:
100 %; LE/DR: 4/D) [12–14]. In any case, the ABCCN
should follow updated protocols of therapeutic regimens,
thereby avoiding variability in clinical practice with respect
to administration of oncological procedures and interven-
tions against the occurrence of toxicities (Agreement:
100 %; LE/DR: H). She/he should also assess clinical
parameters for patients with advanced breast cancer, such as
comorbidities, performance status, nutrition, pain, general
prognosis, toxicities, and symptom management (Table 1).
The ESO–ESMO consensus on advanced breast cancer,
developed by the European School of Oncology and the
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European Society for Medical Oncology, with the objective
of improving health outcomes, recommends psychological
care and a personalised approach to patients from the very
moment they are diagnosed [9]. Along these lines, the
expert panel considered that psychological care should be
multidisciplinary (Agreement: 100 %; LE/DR: H). The
ABCCN should pay attention to psychological considera-
tions for patients and their families throughout the process,
and engage in good communication with them, providing
appropriate information at each point in the process
(Agreement: 100 %; LE/DR: 4/D) [9, 15, 16]. Also, it is
recommended that the ABCCN monitors patients’ anxiety
levels, so that psychological abnormalities that must be
addressed by mental health professionals could be early
detected (Agreement: 100 %; LE/DR: 4/D) [17].
As advanced breast cancer is a chronic disease, it is
important to highlight the ABCCN’s role as a coach.
Coaching tools improve adherence to treatment and control
of adverse effects, as well as the patients’ health education
assimilation (Agreement: 88 %; LE/DR: H). The ABCCN
should apply communication techniques, such as active
listening and empathy, and promote patients’ active par-
ticipation in their health process and autonomy (Agree-
ment: 100 %; LE/DR: 4/D) [14, 18, 19]. In this regard, it is
also relevant to offer solid health education.
Education and research role
The ESO–ESMO guidelines recommend that all patients
with advanced breast cancer receive comprehensive, cul-
turally sensitive, up-to-date and easy-to-understand infor-
mation about their disease and its management (level of
evidence IB) [9]. Patients should understand that, at pre-
sent, advanced breast cancer is treatable but not curable,
although some patients can live with the disease for very
long periods of time. Education should be started to teach
patients and their families to recognise and treat the dif-
ferent adverse effects of the treatment received (Agree-
ment: 100 %; LE/DR: 4/D) [9, 10]. The ABCCN should
teach, advise and guide patients and caregivers with respect
to the disease and treatments, as well as to healthy living
habits related to diet, exercise, rest and sleep (Agreement:
100 %; LE/DR: 4/D) [9, 10]. In more advanced phases of
the disease, she/he must focus education on the manage-
ment of symptoms, including pain or anxiety, applying the
best continuous care available to patients (Agreement:
100 %; LE/DR: H). One suggestion is organising training
activities with patients and their families regarding differ-
ent problems and concerns, which may be previously
identified through patient surveys. Holding workshops with
them is an effective way to provide specific training, by
giving them the chance to share their experiences and
concerns among equals and, at the same time, to receive
suggestions that may be an opportunity for change
(Agreement: 100 %; LE/DR: H). Also, it is important to
establish both individual and group education protocols
(Agreement: 100 %; LE/DR: H).
The ABCCN can offer training related to the process of
advanced breast cancer, not only to patients but also to
other health professionals, covering those subjects that
each professional requires at her/his care level (Agreement:
100 %; LE/DR: H). The ABCCN can also act as a mentor
to students completing their internships in the Oncology
unit, focusing on the global vision of the process of
advanced breast cancer and recognising her/his role and
how the care provided to patients should be (Agreement:
100 %; LE/DR: H). At the same time, she/he should par-
ticipate in the process of training nursing residents, to
ensure the consolidation of advanced practice in the care of
patients with advanced breast cancer (Agreement: 100 %;
LE/DR: 4/D) [20, 21]. Owing to the chronic nature of the
disease, there is direct contact with primary care. Thus, it
would be useful for the nursing staff at health centres to
know the protocols for action, the management of symp-
toms, pain and adverse effects, the handling of technical
devices such as reservoirs and peripherally inserted central
catheters and palliative patient care (Agreement: 100 %;
LE/DR: H). The expert panel came to a consensus on
offering training to other non-oncology units that may care
for patients with advanced breast cancer (Agreement:
88 %; LE/DR: H), as well as to oncologists, since their
knowledge of the nursing care needs of patients is often
limited (Agreement: 88 %; LE/DR: H).
In the course of the teaching and clinical work, the
ABCCN should make use of resources that may serve as a
vehicle for conveying accurate and comprehensible infor-
mation to patients regarding their disease, treatment,
adverse effects and sequelae (Agreement: 88 %; LE/DR:
H). These resources may be presented on paper (manuals
and glossaries of terms, newspapers, individualised and
standardised medication regimens and lists of adverse
effects and their management), involve telematics (tele-
phone consultation, interactive digital platforms, websites,
Table 1 Clinical parameters recommended to be evaluated by the
ABCCN
Clinical parameters Agreement (%) LE/DR
Comorbidities 88 H
ECOG score 88 H
Nutritional considerations 100 H
Pain assessment 100 H
Prognosis 100 H
Current and residual toxicities 100 H
Symptom management 100 H
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patient associations and single-subject workshops) or
healthcare services (social work, psycho-oncology, nutri-
tion, physiotherapy and primary care) (Agreement: 100 %;
LE/DR: H).
Case management role
Patients with advanced breast cancer require continuous
care from different health professionals who meet their
needs whenever they arise. Therefore, the role of the
ABCCN as case manager has also been established [14].
The expert panel agreed that the ABCCN should supervise
and evaluate the different healthcare options and services
offered to patients and their families (Agreement: 88 %;
LE/DR: 4/D) [22, 23]. The ABCCN should also take care
of logistical considerations such as moving up appoint-
ments, fostering the coordination of different appointments
in a single visit, shortening waiting times and managing
transfers, all to minimise the psychosocial impact on
patients and those around them (Agreement: 100 %; LE/
DR: 4/D) [22, 23]. Finally, the ABCCN must act in col-
laboration with the multidisciplinary team, engaging in
direct communication with patients and families and pro-
viding information on the steps in the care process
(Agreement: 100 %; LE/DR: 4/D) [22, 23].
Professional profile
While no evidence was found with respect to how much
experience is required to perform the role of ABCCN, the
participating experts agreed a minimum of 2 years of
continuous experience with oncology patients to be able to
perform the role of ABCCN with certain minimum guar-
antees (Agreement: 100 %; LE/DR: H). Various publica-
tions were evaluated to find out the ideal training, and
while some of them favour having a specific certification to
practise this role, others believe that a degree in health
science or simple experience is enough [23–27]. To
achieve the skills, knowledge and attitudes required to
work efficaciously, efficiently and effectively, it is advis-
able to have specific training in oncology (Agreement:
100 %; LE/DR: 4/D), mainly in clinical, case management
and counselling aspects (Agreement: 100 %; LE/DR: H).
There is no oncology nursing specialty within the cur-
rent panorama of qualified training in Spain. However, it is
important to design a face-to-face or remote continuous
education programme for ABCCN (Agreement: 100 %;
LE/DR: H) that covers all considerations related to com-
prehensive care of patients, their physical and psychosocial
considerations and those of their families (Agreement:
100 %; LE/DR: 4/D) [23]. The ABCCN should receive
specific training in lines of treatment, care and treatment
protocols, adverse effects, pain management, palliative
care, communication skills and counselling (Agreement:
88 %; LE/DR: 4/D) [23, 28]. At the same time, she/he
should receive training in research, promoting and foster-
ing the performance of this role and in the different clinical
trials in which patients are likely to participate (Agreement:
88 %; LE/DR: H). Consequently, the ABCCN can also act
as healthcare collaborator in clinical research (Agreement:
100 %; LE/DR: 4/D) and as research nurse, acting as
principal investigator in nursing care studies (Agreement:
88 %; LE/DR: 4/D) [29].
Also, from the expert panel, scientific societies are
advised to drive the creation of accreditations to assess the
nursing curriculum, taking into account matters such as
training, teaching, research or care provided (Agreement:
100 %; LE/DR: H). The ABCCN also requires a broad
knowledge of the treatment protocols for advanced breast
cancer and the operations at the centre where she/he works,
as well as being informed of research activities. The
ABCCN should know about and participate on breast
cancer committees, be familiar with the resources available
to offer help to patients both inside and outside of the
hospital and know about patient associations, support
groups and different complementary therapies (Agreement:
100 %; LE/DR: 3/D) [30].
Competencies
The Spanish Society of Oncology Nursing (SEEO,
according to its Spanish acronym) has been aware of the
need to promote the establishment of nursing competencies
in cancer patients and research within this framework. In
this regard, a specific competency framework for oncology
nurses was established at the second SEEO conference in
2005 [30]. The expert panel also formulated recommen-
dations on the ABCCN’s competencies (Table 2).
Skills
To effectively assume the role of ABCCN, certain specific
skills should be acquired. The ABCCN establishes a rela-
tionship of confidence with their patients, thus facing the
possibility of being emotionally affected by their patients’
situation. She/he should have emotional self-knowledge
and recognise her/his emotions and how they can affect in a
high-risk department (Agreement: 100 %; LE/DR: H). The
ABCCN must always be conscious of her/his mood, as this
could influence her/his behaviour (Agreement: 100 %; LE/
DR: H). Also, the ABCCN should be capable of exercising
self-control and self-motivation and of channelling her/his
own emotions towards an objective, focusing on goals and
trying to overcome obstacles (Agreement: 100 %; LE/DR:
H). She/he should be capable of experiencing empathy,
recognising the emotions of others, knowing how to
254 Clin Transl Oncol (2017) 19:251–260
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interpret what is happening to patients, understanding them
and performing an assertive analysis of specific situations
(Agreement: 100 %; LE/DR: H). Finally, the ABCCN
should be competent in social skills, valuing interpersonal
relationships as essential to human well-being and having
certain values, such as tolerance, communicative abilities
and knowledge of how to persuade people, negotiate with
them, calm them down and reconcile situations of conflict
(Agreement: 100 %; LE/DR: H).
The ABCCN interacts with a multidisciplinary team,
patients and their families and caregivers, as well as with
healthcare and social systems. To do this, she/he must
possess conflict resolution skills. The ABCCN should
approach the conflict by applying a set of rules, through
basic consensus between the parties (Agreement: 100 %;
LE/DR: H). When there is no clear consensus, the
ABCCN needs skills and experience to help approach
different positions (Agreement: 100 %; LE/DR: H).
Problem resolution should be done through a participatory
process in which all parties jointly determine what the
problem is and come to a resolution (Agreement: 100 %;
LE/DR: H). The ABCCN should be capable of negoti-
ating and assessing whether a conflict is resolved and
whether the parties involved are satisfied (Agreement:
100 %; LE/DR: H).
Teamwork is crucial to approach cancer management
with unified criteria [31]. Regarding teamwork skills, it
was agreed that the ABCCN should be capable of
proposing, analysing, consulting and implementing meth-
ods that enhance the healthcare process together with the
rest of the members of the interdisciplinary team (Agree-
ment: 100 %; LE/DR: H). With the objective of improving
the relationships between the people involved in the dif-
ferent processes, the ABCCN should be capable of agree-
ing upon shared objectives for the healthcare plan and of
actively participating in meetings, sessions and other
activities that foster multidisciplinary work (Agreement:
100 %; LE/DR: H).
Table 2 Competencies of the ABCCN
Group Recommendation Agreement (%) LE/DR
Patient assessment Perform the patient assessment systematically (both objective and subjective
data) and record it within the conceptual framework adopted in the
department
100 H
Analyse the data and draw conclusions for subsequent care 100 H
Share the data with the rest of the team 100 H
Skilfully manage the capacity to evaluate, diagnose and treat patients, within
the professional boundaries of nursing
100 H
Clinical management Diagnose (identify problems), plan interventions, execute (including
interdependent and autonomous nursing interventions) and perform a final
assessment. This process requires a continuous evaluation of the care plan
and makes it possible to decide whether the objectives of the care plan
established have been reached
100 H
Offer comprehensive care to patients, based on scientific evidence 100 H
Involve patients’ families and/or loved ones in care 100 H
Duly inform patients so that they are capable of making appropriate decisions
at every point in their disease
88 H
Know what the healthcare system offers, to be able to inform patients and
help them move within this framework
100 H
Coordinate the care offered to patients with the rest of the therapeutic team
and ensure that care is continuous
100 H
Know the ethical and legal principles that should govern nursing practice and
incorporate them into care
100 H
Counselling/coaching Assess, at their first appointments, patients’ and families’ capacities for and
attitudes towards learning about lifestyle throughout the disease process
100 H
Bear in mind patients’ values and beliefs and consider the coping
mechanisms at their disposal, to deal with the disease at each stage
100 H
Prepare patients by proposing short- and medium-term objectives 100 H
Mobilise patients’ personal resources and provide tools to achieve short- and
medium-term objectives
100 H
Support patients and families at different points in the experience of living
with cancer
100 H
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Healthcare process for advanced breast cancer
patients
It is necessary to establish a healthcare track for patients
with advanced breast cancer, to keep them from not visit-
ing the ABCCN owing to a lack of information (Agree-
ment: 100 %; LE/DR: H). Initially, access of patients to
the ABCCN should be convenient and hassle-free, through
her/his own visit schedules. An initial visit is required
when patients are diagnosed and referred from medical
consultation, and successive appointments must then be
scheduled, depending on the assessment and patients’
needs. The participating experts established
recommendations and came to a consensus on a circuit for
how to develop advanced breast cancer patients’ care, as
described in Fig. 1.
Patients with advanced breast cancer may have many
and varied needs throughout the process. It is, therefore,
necessary to establish the circumstances that call for
intervention by an ABCCN. Diagnosis requires an initial
intervention for assessment and a first contact to evaluate
therapies, symptoms, adverse effects, anxiety and pain
control (Agreement: 88 %; LE/DR: H). Also, the ABCCN
should facilitate contact with other professionals, either at
the level of hospital care (psycho-oncology, rehabilitation
and diagnostic support services—radiology, pathology,
Fig. 1 Decision-making and
assistance algorithm for
advanced breast cancer patients
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nuclear medicine, among others) or at the level of primary
care, liaison nurses, palliative home care, social workers,
etc. (Agreement: 100 %; LE/DR: H).
Implementation process
Key nurses or liaison nurses, who are focused on cancer
either in general or on particular types, are relatively new
in the Spanish healthcare system. Therefore, there is
insufficient experience on which criteria should be evalu-
ated when implementing this type of role, although the
literature points to an achievement of greater effectiveness
and efficiency in patient care [32]. The expert panel rec-
ommended assessing the implementation of a key position
such as the ABCCN if the following criteria are
considered:
• Reducing the impact of hospital fragmentation caused
by the application of the therapeutic plan, and offering
a coherent and simple environment for patients.
• Eliminating the gaps that may arise in a multidisci-
plinary care system.
Fig. 2 Implementation process
of the ABCCN’s position
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• Improving the patient experience by eliminating or
reducing negative situations that could be prevented or
mitigated.
• Promoting patient empowerment throughout the health-
care process, especially in stages of greater vulnerabil-
ity such as diagnosis, recurrence and treatments
(Agreement: 100 %; LE/DR: H).
The first step in the implementation process on which
the authors of this document have come to a consensus
(Fig. 2) is the evaluation of the need for an ABCCN. It is
advisable to drive this implementation in a coordinated
manner with institutional support and evaluation (Agree-
ment: 100 %; LE/DR: H).
For the designation of the ABCCN, it is advisable to
have a description of the position, based on the professional
profile, competencies and skills (Agreement: 88 %; LE/
DR: H), in addition to a specific methodology for assessing
competencies (assessment of professional CV, knowledge,
abilities and aptitudes) (Agreement: 100 %; LE/DR: H).
It is appropriate to be careful with the method of initi-
ation at the institution. Introducing the ABCCN to other
healthcare professionals may be a novel event, especially at
centres that do not have similar previous experience in
other areas, and it should ideally be done by managers or
corresponding authorities, through a formal introduction to
all the departments and units involved in the field of action
of the ABCCN (Agreement: 100 %; LE/DR: H). At the
same time, the start of this new role and its objectives,
responsibilities and location should be communicated by
the usual means (intranet, for instance) (Agreement:
100 %; LE/DR: H). It would be beneficial to have previ-
ously worked with the multidisciplinary team, introducing
the ABCCN and agreeing upon their objectives and roles
(Agreement: 100 %; LE/DR: H). Also, it is advisable to
agree with this team upon a gradual introduction that
allows for effective learning (Agreement: 100 %; LE/DR:
H).
Recording the activity of the ABCCN is also considered
to be important, and the expert panel agreed that this
should be included in the institution’s usual schedules
(face-to-face or telephone visits, telephone emergency
care, telemedicine, etc.) (Agreement: 100 %; LE/DR: H).
At the same time, it is also advisable to define some
ABCCN activity indicators (Agreement: 100 %; LE/DR:
H), although there are other activities associated with this
role that require time but are difficult to quantify, such as
case management (Agreement: 100 %; LE/DR: H). Some
examples of healthcare activity indicators could be:
attributable periods of time in the healthcare process,
number of emergencies owing to treatment toxicity, num-
ber of central catheters in treatments that carry a risk of
chemical phlebitis, adherence to oral treatments and
referrals through screening to nutrition, psycho-oncology
or oncogeriatrics departments, etc.
Conclusions
The care of cancer patients has undergone substantial
changes in recent years. Their physical and psychological
needs should be handled appropriately through continu-
ously provided care, and their demands should be met in all
phases of the disease. In the case of ABC, there is a wide
range of therapeutic options, support measures, required
resources as well as a considerable number of specialists
who are involved in the management. This contributes to
the complex nature of these patients’ follow-up.
The SEOM Handbook on Continuous Oncology Care
recommends coordinating and optimising all available
healthcare and social resources, fostering the integration of
all healthcare levels and building comprehensive oncology
care, with the aim of improving patient’s quality of life
[33]. The ESMO–ESO consensus on advanced breast
cancer recommended including a nurse specialised in
oncology (if possible, breast cancer) in the multidisci-
plinary team in charge of managing patients with advanced
breast cancer [9], clearly showing the need to add a key
figure in the care of these patients.
Key nurses in cancer are referred to by many names,
depending on the country in which they practise nursing
and the roles they perform: Healthcare Coordinators,
Patient Navigators, Health Coaches, Care Managers,
Nursing Case Managers, Oncology Nursing Navigators,
Oncology Patient Navigators and Key Oncology Nurses are
just some of these names [23, 34]. This curriculum has
established the definition and roles of the ABCCN, as well
as the skills and professional profile which, in any case,
may be developed by professionals who are also in charge
of other roles or specialists in other areas.
The roles of nurses specialised in oncology should
include assessment of individual patient needs, education,
coordination, communication and support provided to
patients, implementation of effective transitions in the
course of the disease and evaluation of the consequences
for patients, families and the organisation [34]. The clinical
role of ABCCN has paid special attention to psychological
considerations, healthcare education and coaching for
patients and families and has focused on managing symp-
toms, pain and anxiety. Likewise, the roles of case workers
have also been established previously [14, 19, 23, 35, 36],
and this consensus document recommends that the ABCCN
takes logistical measures to minimise the psychosocial
impact on patients and their loved ones, such as moving up
appointments, fostering coordination of appointments in a
single visit and shortening waiting times.
258 Clin Transl Oncol (2017) 19:251–260
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This document establishes several requirements in terms
of training and personal skills for the ABCCN and rec-
ommends the provision of specific continuing education in
lines of treatment, healthcare protocols, adverse effects,
pain management, palliative care, care for terminally ill
patients, communication, counselling and clinical research
skills.
Following the course set in 2005 by the SEEO at its
second conference [30], where a specific competency
framework for oncology nurses was established, the
authors of this document formulated and validated a set of
recommendations on the ABCCN’s competencies with
respect to patient assessment, clinical management, coun-
selling and coaching.
In summary, this consensus document will be a useful
tool to improve the care and quality of life of patients with
advanced breast cancer throughout the entire care process.
It presents expert agreements and recommendations on the
care provided by specialised nurses to patients with
advanced breast cancer. It also establishes the profile and
roles of the ABCCN, the healthcare process in which she/
he participates and the resources required to perform her/
his activity.
The present manuscript provides an implementation
algorithm that can be useful for those centres without
previous experience in creating specialised nursing roles or
with difficulties in implementing such positions as an
ABCCN. Finally, it recommends evaluating the need for
reducing the impact of fragmentation of services, offering
patients a simpler and more coherent environment, elimi-
nating the gaps that may arise in multidisciplinary care,
improving the patient experience and promoting patient
empowerment throughout the healthcare process before
starting implementation.
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